Ang, C. W., Laman, J. D., Willison, H. J., Wagner, E. R., Endtz, H. P., De Klerk, M. A., . . . Doorn, P. A. V. (2002). Structure of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients. American Society for Microbiology (ASM).
Chicago-stil citatAng, C. W., et al. Structure of Campylobacter Jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients. American Society for Microbiology (ASM), 2002.
MLA-referensAng, C. W., et al. Structure of Campylobacter Jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients. American Society for Microbiology (ASM), 2002.